Valuation (12%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 136.70 | N/A |
| PEG Ratio (TTM) | -9.11 | N/A |
| P/S Ratio (TTM) | N/A | N/A |
| P/B Ratio (TTM) | 5.71 | N/A |
| P/FCF Ratio (TTM) | -19.37 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.26% | N/A |
| ROE (TTM) | 4.60% | N/A |
| Net Profit Margin (TTM) | N/A | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 104.90% | N/A | N/A |
| Revenue | N/A | N/A | N/A |
| Net Income | 99.58% | N/A | N/A |
| Cash Flow | 671.66% | N/A | N/A |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.06 | N/A |
| Quick Ratio (TTM) | 0.06 | N/A |
| D/E Ratio (TTM) | 0.05 | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 3 | N/A |
| Altman Z-Score | 11.21 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |